Jun 14, 2019 - Key developments of the week include Merck's (MRK) deal to buy Tilos Therapeutics and FDA approval for Roche's (RHHBY) polatuzumab vedotin and Merck's Keytruda.
Jun 14, 2019 - Dassault's acquisition of Medidata (MDSO) to close by 2019-end.
Jun 07, 2019 - The case, which is premised on a unproven legal theory, could impact the course of future opioid litigation.
Jun 07, 2019 - Pharma bigwigs present data from cancer studies at ASCO. Lilly's (LLY) CGRP Emgality gets FDA approval for episodic cluster headache in adults.
Jun 06, 2019 - Celgene (CELG) along with partner Acceleron submits application for luspatercept to the FDA.
Jun 06, 2019 - Top Stock Reports for Johnson & Johnson, Chevron & Adobe
Jun 05, 2019 - There's more good news with the fight against cancer than you might think.
May 29, 2019 - Allergan's (AGN) sNDA for Vraylar gets the FDA approval for the treatment of adult patients with major depressive episodes related to bipolar I disorder.
May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
May 28, 2019 - And the analyst really likes one in particular.